Access the full text.
Sign up today, get DeepDyve free for 14 days.
From the Service d'Hématologie Biologique
T. Vassiliadis, A. Mpoumponaris, S. Vakalopoulou, O. Giouleme, Dimitrios Gkissakis, N. Grammatikos, K. Soufleris, A. Kakafika, K. Tziomalos, K. Patsiaoura, V. Papanikolaou, N. Evgenidis (2010)
Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survivalHepatology Research, 40
B. Gerber, G. Stussi (2011)
Reversibility of spur cell anemia.Blood, 118 16
A 61‐year‐old‐female presented with jaundice, massive ascites, and hepatic encephalopathy. She had no history of alcohol consumption, but had been diagnosed with primary biliary cirrhosis 8 years earlier. Laboratory tests indicated the following: Hb level 6.2 g/dL (reference value [RV], 12‐16.5 g/dL), WBC count 10.7 × 10 9 /L (RV, 4 × 10 9 ‐10 × 10 9 /L), PLT count 51 × 10 9 /L (RV, 150 × 10 9 ‐400 × 10 9 /L), reticulocyte count 318 × 10 9 /L (RV, 40 × 10 9 ‐120 × 10 9 /L), cholesterol level 2.09 g/L (RV, 1.5‐2.6 g/L), decreased HDL 0.22 g/L (vascular protection threshold, >0.6 g/L), triglycerides 1.2 g/L (RV, 0.6‐1.5 g/L), increased LDL 2.79 g/L, AST 60 UI/mL (RV, <31 UI/mL), ALT 25 UI/mL (RV, <34 UI/mL), alkaline phosphatase 138 UI/L (RV, 30‐120 UI/L), total bilirubin 199 mg/mL (RV, 1‐14 mg/mL), coagulation factor V 0.45 (RV, >0.7), LDH 968 UI/L (RV, <248 UI/L), and haptoglobin <0.08 g/L (RV, 0.3‐2 g/L). The DAT was negative. The blood smear (see figure, blood cell film [May‐Grünwald‐Giemsa ×1000]) demonstrated abundant spur cells in a background of moderate anisopoikilocytosis without schistocytes. Spur cells are acanthocytes with cytoplasmic projections irregularly distributed over the surface of the RBCs. RBC survival is shortened due to splenic sequestration and destruction. Changes in serum lipids affect the composition of the lipids of the RBC membrane with imbalance in cholesterol/phospholipid ratio. The membrane fluidity decreases as the cholesterol content increases leading to an irreversible rigid transformation and peculiar shapes as in our case. Spur cell formation is enhanced in chronic liver disease due to: 1) impairment of the liver's ability to esterify cholesterol, causing free cholesterol to bind to the RBC membrane and increasing its surface area; 2) the stagnation of sterols on the RBC membrane; 3) changes in plasma lecithin‐cholesterol acyltransferase concentrations; and 4) the retention of bile acids. It has also been suggested that spur cells were acanthocytes remodeled by the spleen, whereby the spicules become more blunt and the associated membrane loss makes the cell more spherocytic (spheroacanthocytes). Spur cell anemia is an uncommon acquired nonimmune hemolytic anemia associated with severe liver disease. Identifying such cells can be important to rule out DAT‐negative immune hemolytic anemia. Most patients have advanced liver failure related to alcoholic cirrhosis. Primary biliary cirrhosis is a rare cause. There is no effective therapy except liver transplantation, but the prognosis remains poor. CONFLICT OF INTEREST No conflict of interest for both authors.
Transfusion – Wiley
Published: Jan 1, 2013
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.